Poseida Therapeutics, Inc. Operating Lease, Liability, Current
Poseida Therapeutics, Inc. had Operating Lease, Liability, Current of $6.08 million as of 2024-09-30, per its 10-Q filed 2024-11-07.
Financial Statements › Notes › Leases
us-gaap:OperatingLeaseLiabilityCurrent · last filed 2024-11-07
- 2024-09-30: Operating Lease, Liability, Current $6.08M.
- 2024-06-30: Operating Lease, Liability, Current $6.04M.
- 2024-03-31: Operating Lease, Liability, Current $6.00M.
- 2023-12-31: Operating Lease, Liability, Current $5.95M.
| Period end | Operating Lease, Liability, Current |
|---|---|
| 2024-09-30 | $6.08M 10-Q · filed 2024-11-07 |
| 2024-06-30 | $6.04M 10-Q · filed 2024-08-05 |
| 2024-03-31 | $6.00M 10-Q · filed 2024-05-14 |
| 2023-12-31 | $5.95M 10-Q · filed 2024-11-07 |
| 2023-09-30 | $5.91M 10-Q · filed 2023-11-09 |
| 2023-06-30 | $5.86M 10-Q · filed 2023-08-08 |
| 2023-03-31 | $5.82M 10-Q · filed 2023-05-09 |
| 2022-12-31 | $5.87M 10-K · filed 2024-03-07 |
| 2022-09-30 | $6.74M 10-Q · filed 2022-11-10 |
| 2022-06-30 | $6.69M 10-Q · filed 2022-08-11 |
| 2022-03-31 | $7.39M 10-Q · filed 2022-05-12 |
| 2021-12-31 | $6.34M 10-K · filed 2023-03-09 |
| 2021-09-30 | $5.43M 10-Q · filed 2021-11-09 |
| 2021-06-30 | $5.64M 10-Q · filed 2021-08-12 |
| 2021-03-31 | $5.85M 10-Q · filed 2021-05-11 |
| 2020-12-31 | $4.81M 10-K · filed 2022-03-10 |
| 2020-09-30 | $4.20M 10-Q · filed 2020-11-12 |
| 2020-06-30 | $4.18M 10-Q · filed 2020-08-20 |